Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhanced Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Post-Trans-arterial Chemoembolization: A Prospective Study Using Twin Internally Cooled-Perfusion Electrodes

NCT07192172 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT07192172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07192172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhanced Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma Post-Trans-arterial Chemoembolization: A Prospective Study Using Twin Internally Cooled-Perfusion Electrodes
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2017
Completion date
December 1, 2020
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma, liver neoplasms